AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Nasal Flu Vaccine Enters Safety, Immunogenicity Trials.(Brief Article)
2001 JUN 13 - (NewsRx.com & NewsRx.net) --
ID Biomedical Corp. has initiated expanded human safety and immunogenicity studies of the company's subunit intranasal influenza vaccine.
The first group of healthy adult volunteers has been enrolled in the study, which is being conducted at the University of Rochester, New York, under the direction of Dr. John Treanor, Associate Professor of Medicine and principal investigator. Target enrollment is 100 subjects.
This study will provide expanded safety data for the prototype monovalent intranasal flu vaccine. As a follow-up to positive results in a recently reported Phase I trial, this study will characterize the immune responses elicited by several vaccine regimens in persons who have had a variety of previous immunologic experience with influenza.
"The results from this clinical trial will help us determine the most attractive doses and dosing regime to investigate in subsequent clinical trials," said Dr. Louis Fries, ID Biomedical. "Our next clinical trial, scheduled for this fall, will study our trivalent flu vaccine in healthy adults prior to moving to Phase II testing. The information we're gathering now will help us optimize the design of that trial."
Results from a previous human trial, reported by Treanor on April 24, 2001 at the ...
- ID Biomedical's flu vaccine granted Fast Track status by FDA.
- Press release article from: PR Newswire July 12, 2005 700+ words
...this year, ID Biomedical announced that its flu vaccine was eligible...injectable flu vaccine," said Jane Halpern, ID Biomedical's Vice President...population. ID Biomedical produces Fluviral...from its two flu vaccine production...
- GlaxoSmithKline of Research Triangle Park has agreed to acquire flu vaccine...
- Newspaper article from: BT Catalyst September 1, 2005 700+ words
GlaxoSmithKline of Research Triangle Park has agreed to acquire flu vaccine company ID Biomedical of Vancouver, British Columbia, for about $1.4 billion.
- ID Biomedical announces positive results from ongoing human trial of intranasal...
- Press release article from: PR Newswire October 18, 2001 700+ words
...intranasally delivered flu vaccine. We are very...Louis Fries, ID Biomedical's VP of Clinical...single dose." ID Biomedical's flu vaccine is based on...dose of our flu vaccine," added Dr. Holler. About ID Biomedical ID ...
- GSK OFFERING $1.4B TO BUY ID BIOMEDICAL, FLU VACCINE.
- Magazine article from: BIOWORLD Today Pihl-Carey, Karen September 8, 2005 700+ words
...approval of its flu vaccine Fluarix, but...Columbia- based ID Biomedical would bring GSK...over others. ID Biomedical currently supplies...percent of its flu vaccine, and it received...of its expected flu vaccine supply due to...manufacturing facility, ...
- ID Biomedical files I.N.D. for nasal flu vaccine trial.
- Press release article from: PR Newswire November 13, 2001 700+ words
...intranasally- delivered flu vaccine that is designed...Dr. Louis Fries, ID Biomedical's VP of Clinical...Affairs. "For a flu vaccine to be commercially...a single dose." ID Biomedical's flu vaccine is based on the Company...
- ID Biomedical begins trivalent nasal flu vaccine study; FluINsure(TM) is...
- Press release article from: PR Newswire December 20, 2001 700+ words
...also correlate with protection against the virus. ID Biomedical's flu vaccine is based on the Company's proprietary vaccine...that includes the hemagglutinin protein. About ID Biomedical ID Biomedical Corporation is a North American based...
- ID Biomedical begins trivalent nasal flu vaccine study.(Vaccine for prevention...
- Newspaper article from: BIOTECH Patent News December 1, 2001 700+ words
...also correlate with protection against the virus. ID Biomedical's flu vaccine is based on the company's proprietary vaccine...proteins that includes the hemagglutinin protein. ID Biomedical is a North American based biotechnology company...
- ID Biomedical to ship 1.2 million doses of its flu vaccine to the Canadian...
- Press release article from: PR Newswire December 7, 2004 700+ words
...significant demand for flu vaccine in the Canadian...recently contacted flu vaccine manufacturers...very pleased that ID Biomedical will supply the...Executive Officer. ID Biomedical produces Fluviral from its two flu vaccine production facilities...
Source: HighBeam Research, Nasal Flu Vaccine Enters Safety, Immunogenicity Trials.(Brief Article)